| Literature DB >> 34961819 |
Xiaoyu Xu1,2, Wen Deng1,2, Wanqing Zhang1,2, Junhua Zhang1,2, Muchen Wang1,2, Si Shan1,2, Hongning Liu1,2.
Abstract
The increasing use of moxibustion has led to a debate concerning the safety of this treatment in human patients. Inhalation of cigarette smoke induces lung inflammation and granulomas, the proliferation of alveolar epithelial cells, and other toxic effects; therefore, it is important to assess the influence of inhaled moxa smoke on the lungs. In the present study, a novel poisoning cabinet was designed and used to assess the acute toxicity of moxa smoke in rats. We evaluated pathological changes in rat lung tissue and analyzed differentially expressed genes (DEGs) using RNA-seq and transcriptomic analyses. Our results show that the maximum tolerable dose of moxa smoke was 290.036 g/m³ and LC50 was 537.65 g/m³. Compared with that of the control group, the degree of inflammatory cell infiltration in the lung tissues of group A rats (all dead group) was increased, while that in group E rats (all live group) remained unchanged. GO and KEGG enrichment analyses showed that the DEGs implicated in cell components, binding, and cancer were significantly enriched in the experimental groups compared with the profile of the control group. The expressions of MAFF, HSPA1B, HSPA1A, AOC1, and MX2 determined using quantitative real-time PCR were similar to those determined using RNA-seq, confirming the reliability of RNA-seq data. Overall, our results provide a basis for future evaluations of moxibustion safety and the development of moxibustion-based technology.Entities:
Year: 2021 PMID: 34961819 PMCID: PMC8710166 DOI: 10.1155/2021/5107441
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1Emergency poisoning cabinet constructed in-house.
Moisture content of moxa sticks.
| No. | Initial weight (g) | Final weight (g) | Absolute moisture content (%) | Relative moisture content (%) |
|---|---|---|---|---|
| 1 | 3.03 | 2.73 | 10.99 | 9.90 |
| 2 | 3.56 | 3.25 | 9.54 | 8.71 |
| 3 | 3.25 | 2.95 | 10.17 | 9.23 |
| 4 | 3.48 | 3.15 | 10.48 | 9.48 |
| 5 | 3.42 | 3.09 | 10.68 | 9.65 |
| 6 | 3.12 | 2.79 | 11.83 | 10.58 |
| Mean ± SD | 3.31 ± 0.21 | 2.99 ± 0.21 | 10.62 ± 0.77 | 9.59 ± 0.63 |
Ash content of moxa sticks.
| No. | Weight of moxa stick (g) | Weight of ash (g) | Absolute ash content (%) | Relative ash content (%) |
|---|---|---|---|---|
| 1 | 3.46 | 0.25 | 7.99 | 7.23 |
| 2 | 3.37 | 0.24 | 7.88 | 7.12 |
| 3 | 3.69 | 0.26 | 7.79 | 7.05 |
| 4 | 3.52 | 0.25 | 7.86 | 7.10 |
| 5 | 3.35 | 0.24 | 7.92 | 7.16 |
| 6 | 3.53 | 0.25 | 7.83 | 7.08 |
| Mean ± SD | 3.49 ± 0.12 | 0.25 ± 0.01 | 7.88 ± 0.07 | 7.12 ± 0.06 |
The rate of moxa smoke generation.
| No. | Weight of moxa stick (g) | O2 Concentration before combustion (%) | O2 Concentration after combustion (%) | Weight of ash (g) | Rate of moxa smoke generation (%) |
|---|---|---|---|---|---|
| 1 | 10.66 | 21.4 | 20.9 | 0.76 | 84.62 |
| 2 | 24.32 | 20.9 | 20.0 | 1.73 | 84.33 |
| 3 | 39.94 | 21.4 | 19.8 | 2.84 | 84.43 |
| Mean ± SD | 24.97 ± 14.65 | 21.23 ± 0.29 | 20.23 ± 0.59 | 1.78 ± 1.04 | 84.46 ± 0.15 |
Results of acute toxicity assessment.
| Group | Animal number | Body weight ( | Weight of moxa stick (g) | Dose (g/m3) | Number of dead rats | Mortality rate ( |
|
|---|---|---|---|---|---|---|---|
| A | 6 | 307.62 ± 7.05 | 151.33 | 639.067 | 6 | 100% | 1 |
| B | 6 | 318.97 ± 16.62 | 128.06 | 540.797 | 6 | 100% | 1 |
| C | 6 | 361.99 ± 9.75 | 112.51 | 475.130 | 4 | 66.7% | 0.445 |
| D | 6 | 310.51 ± 8.38 | 86.41 | 364.909 | 1 | 16.7% | 0.028 |
| E | 6 | 339.67 ± 9.97 | 68.68 | 290.036 | 0 | 0 | 0 |
Organ index.
| Group | Animal number | Number of moxa stick | Weight of moxa stick (g) | Lung weight/body weight (mg/g) |
|---|---|---|---|---|
| Control | 6 | — | — | 4.93 ± 0.57 |
| A | 6 | 7 | 151.33 | 7.67 ± 1.56∗∗ |
| B | 6 | 6 | 128.06 | 7.17 ± 1.68∗∗ |
| C | 6 | 5 | 112.51 | 5.58 ± 1.21 |
| D | 6 | 4 | 86.41 | 6.40 ± 2.29 |
| E | 6 | 3 | 68.68 | 5.23 ± 0.51 |
Figure 2Microscopic images of lung pathology (H&E, ×200).
Summary of trimming and read mapping of RNA sequences extracted from lung tissues with or without exposure to moxa smoke.
| Sample | Raw reads | Clean reads | Total mapped | Multiple mapped | Uniquely mapped |
|---|---|---|---|---|---|
| Control-1 | 50,173,870 | 49,796,126 | 47,428,880 (95.25%) | 2,917,603 (5.86%) | 44,511,277 (89.39%) |
| Control-2 | 46,114,692 | 45,781,086 | 42,990,282 (93.9%) | 2,799,797 (6.12%) | 40,190,485 (87.79%) |
| Control-3 | 52,445,922 | 52,079,738 | 49,504,389 (95.05%) | 3,096,088 (5.94%) | 46,408,301 (89.11%) |
| Control-4 | 48,545,612 | 48,217,204 | 45,990,652 (95.38%) | 2,991,351 (6.2%) | 42,999,301 (89.18%) |
| Control-5 | 50,992,444 | 50,562,024 | 48,161,499 (95.25%) | 3,224,105 (6.38%) | 44,937,394 (88.88%) |
| Control-6 | 50,544,782 | 50,169,430 | 47,895,334 (95.47%) | 3,106,564 (6.19%) | 44,788,770 (89.28%) |
| A-1 | 44,935,518 | 44,575,026 | 42,197,588 (94.67%) | 3,049,901 (6.84%) | 39,147,687 (87.82%) |
| A-2 | 50,700,004 | 50,338,410 | 47,993,769 (95.34%) | 3,186,028 (6.33%) | 44,807,741 (89.01%) |
| A-3 | 50,236,082 | 49,848,242 | 47,350,398 (94.99%) | 3,206,303 (6.43%) | 44,144,095 (88.56%) |
| A-4 | 48,693,504 | 48,333,432 | 45,959,510 (95.09%) | 2,982,521 (6.17%) | 42,976,989 (88.92%) |
| A-5 | 49,146,808 | 48,759,042 | 46,340,404 (95.04%) | 2,945,158 (6.04%) | 43,395,246 (89.0%) |
| A-6 | 53,718,716 | 53,311,266 | 50,690,875 (95.08%) | 3,264,160 (6.12%) | 47,426,715 (88.96%) |
| B-1 | 55,820,604 | 55,423,436 | 52,745,165 (95.17%) | 3,614,618 (6.52%) | 49,130,547 (88.65%) |
| B-2 | 53,589,380 | 53,111,498 | 50,506,434 (95.1%) | 3,334,875 (6.28%) | 47,171,559 (88.82%) |
| B-3 | 55,490,490 | 55,043,366 | 52,450,686 (95.29%) | 3,366,022 (6.12%) | 49,084,664 (89.17%) |
| B-4 | 49,064,936 | 48,628,478 | 46,071,906 (94.74%) | 3,156,726 (6.49%) | 42,915,180 (88.25%) |
| B-5 | 54,094,302 | 53,605,834 | 50,848,156 (94.86%) | 3,618,857 (6.75%) | 47,229,299 (88.1%) |
| B-6 | 50,670,142 | 50,301,200 | 47,808,555 (95.04%) | 3,146,533 (6.26%) | 44,662,022 (88.79%) |
| E-1 | 48,835,796 | 48,411,848 | 46,031,928 (95.08%) | 3,079,255 (6.36%) | 42,952,673 (88.72%) |
| E-2 | 48,866,976 | 48,537,232 | 46,117,663 (95.02%) | 3,002,555 (6.19%) | 43,115,108 (88.83%) |
| E-3 | 55,030,908 | 54,608,348 | 51,926,672 (95.09%) | 3,335,432 (6.11%) | 48,591,240 (88.98%) |
| E-4 | 51,144,428 | 50,682,046 | 48,198,708 (95.1%) | 3,001,808 (5.92%) | 45,196,900 (89.18%) |
| E-5 | 46,247,988 | 45,888,214 | 43,493,626 (94.78%) | 2,855,318 (6.22%) | 40,638,308 (88.56%) |
| E-6 | 52,636,034 | 52,255,560 | 49,672,774 (95.06%) | 3,101,746 (5.94%) | 46,571,028 (89.12%) |
Note. (1) Sample: sample name. (2) Total reads: the number of filtered sequences (clean reads). (3) Total mapped: the number of clean reads that can be mapped to the genome. (4) Multiple mapped: the number of clean reads with multiple alignment positions on the reference sequence. (5) Unique mapped: clean reads with unique alignment position on the reference sequence.
Functional annotation of transcriptome data available in three publicly available protein databases.
| Type | Transcript number (percentage) | Gene number (percent) |
|---|---|---|
| KEGG | 18484 (67.54%) | 13653 (64.86%) |
| GO | 23972 (87.59%) | 18327 (87.06%) |
| COG | 25944 (94.79%) | 19765 (93.90%) |
| Total annotation | 26587 (97.14%) | 20263 (96.26%) |
| Total | 27369 | 21050 |
Figure 3Scatter plots show differences in expression levels. The abscissa and ordinate represent the expression levels of genes/transcripts in the control and experimental groups, respectively. The values of horizontal and vertical coordinates were logarithmically transformed, and each point on the plot represents a specific gene/transcript. The abscissa value of a specific data point represents the expression level of a gene in the control sample, whereas the ordinate value represents the expression level of the same gene in the experimental sample. The red dots in the figure mark genes mark those showing significantly upregulated expression, whereas the blue dots mark those showing significantly downregulated expression. The gray dots indicate genes with no significant changes in expression levels. The greater the deviation from the diagonal line, the greater the difference in the expression level of a gene between the two samples; the closer a data point is to 0, the lower the expression level of that gene is.
Number of differentially expressed genes (DEGs) based on the criteria of |log2FC| ≥ 1 and P < 0.05.
| Group | Total DEG | Upregulated | Downregulated |
|---|---|---|---|
| Control vs. A | 486 | 286 | 200 |
| Control vs. B | 877 | 400 | 477 |
| Control vs. E | 186 | 108 | 78 |
Figure 4GO classification. The ordinate in the figure represents the secondary classification terms of GO. The upper abscissa represents the percentage of genes or transcripts contained in the secondary classification. The lower abscissa represents the number of genes/transcripts contained in the secondary classification. The three colors are used to indicate the three major categories.
Figure 5KEGG pathway enrichment analysis. The vertical axis shows the pathways; the horizontal axis represents the enrichment factor for a particular pathway. The size of the dot corresponds to the number of genes involved in the pathway. The color of the dot corresponds to the P value. Enrichment factor: the ratio of sample number to background number in the pathway.
Figure 6qRT-PCR analysis of the expression levels of the five DEGs examined in this study. Rats in groups A, B, and E were exposed to 151.33, 128.06, and 68.68 g of burned moxa sticks, respectively. Bars represent standard deviation (n = 6). Bars represent means ± SD. P < 0.05; ∗∗P < 0.01.